Co-Amoxiclav 625mg: Uses, Dosage & Side Effects

Co-amoxiclav 625 mg is one of the most commonly prescribed oral antibiotics worldwide, used to treat a range of bacterial infections from sinusitis and tonsillitis to urinary tract and skin infections. Each tablet combines 500 mg of amoxicillin with 125 mg of clavulanic acid, a pairing designed to overcome one of the main ways bacteria resist penicillin-type drugs. The combination is generally well tolerated, though it carries some side effects worth knowing about and a few rare but serious risks that deserve attention.

How the Two Ingredients Work Together

Amoxicillin is a broad-spectrum penicillin that has been in use since the 1970s and remains the most widely prescribed penicillin, both on its own and in combination with clavulanic acid.¹ It works by disrupting the construction of bacterial cell walls, which causes the bacteria to burst and die. The problem is that many bacteria have learned to produce enzymes called beta-lactamases, which chew up amoxicillin before it can do its job.

Clavulanic acid was originally isolated from a soil bacterium called Streptomyces clavuligerus.² On its own it has very weak antibacterial activity, but it permanently latches onto beta-lactamase enzymes and disables them.³ With the beta-lactamases knocked out, amoxicillin is free to attack the cell wall. This is why the combination works against many bacteria that would shrug off amoxicillin alone.

The 625 mg tablet uses a 4:1 ratio of amoxicillin to clavulanic acid, which was the original ratio chosen because clavulanic acid binds so strongly to beta-lactamases that relatively little is needed. Other ratios exist around the world, including 7:1 and 14:1 formulations, but the 4:1 version remains one of the most widely used for standard adult infections.¹

What Co-Amoxiclav 625 mg Is Prescribed For

Doctors reach for co-amoxiclav when they suspect a bacterial infection that could involve beta-lactamase-producing organisms, or when amoxicillin alone has already failed. Common indications include:

• Upper respiratory infections: sinusitis, tonsillitis, and middle ear infections where resistant bacteria are likely.
• Lower respiratory infections: community-acquired pneumonia and bronchitis, particularly when a patient has chronic lung disease.
• Urinary tract infections: especially those caused by E. coli or Klebsiella strains that produce beta-lactamases.
• Skin and soft tissue infections: cellulitis, wound infections, and animal or human bite wounds, where a mix of bacteria is often present.
• Dental infections: abscesses and post-extraction infections that do not respond to simpler antibiotics.

A head-to-head trial comparing co-amoxiclav with two other commonly used antibiotics for acute bacterial tonsillitis found that all three produced similar cure rates by the end of the first week, with co-amoxiclav being well tolerated and showing few self-limiting side effects.⁴

When the Clavulanate May Not Be Necessary

Not every infection that seems like a candidate for co-amoxiclav actually needs the clavulanic acid component. A large retrospective study of nearly 39,000 adults with acute sinus infections found that treatment failure rates were essentially identical whether patients received plain amoxicillin or amoxicillin-clavulanate, at roughly 3.5–3.6% for both groups. Neither antibiotic group even fared significantly better than patients who received no antibiotic at all.⁵ This kind of finding is a reminder that many acute sinus infections are viral, not bacterial, and that when they are bacterial, the added beta-lactamase protection does not always change the outcome. If your doctor prescribes plain amoxicillin for a sinus infection, the evidence supports that choice.

Standard Dosage and Timing

The typical adult dose is one co-amoxiclav 625 mg tablet three times a day, usually for five to seven days depending on the type and severity of infection. Taking it at the start of a meal helps with absorption and reduces the chance of stomach upset. Both amoxicillin and clavulanic acid are absorbed quickly and cleared from the body relatively fast, with half-lives of about one hour and fifteen minutes for amoxicillin and about one hour for clavulanic acid.⁶ Those short half-lives are the reason you take it three times daily rather than once: spacing the doses keeps drug levels high enough to keep killing bacteria throughout the day.

If you miss a dose, take it as soon as you remember and then resume your regular schedule. Do not double up. Finishing the full course matters because stopping early can leave surviving bacteria to multiply and potentially develop resistance.

Dose Adjustments for Kidney Problems

Both components of co-amoxiclav are cleared by the kidneys. When kidney function is reduced, the drug lingers in the body longer and can build to higher-than-intended levels. Guidelines require dose reductions for people with impaired kidney function, and the adjustments depend on how severely the kidneys are affected. Despite this being well known, an audit of hospital prescribing found that among patients with kidney impairment who were prescribed co-amoxiclav, only about half received the correct adjusted dose.⁷ If you have been told you have kidney disease or reduced kidney function, make sure your prescriber knows, because the standard 625 mg dose may be too much.

Common Side Effects

The most frequent complaints are gastrointestinal. Diarrhea, nausea, and occasionally vomiting are the side effects most people notice, and they are largely driven by the clavulanic acid component rather than the amoxicillin. Clavulanic acid stimulates gut motility, which is a polite way of saying it speeds things up inside your intestines. Research in children showed that clavulanic acid triggers strong contractions in the upper small bowel that resemble fasting-state activity, essentially telling the gut to push contents along even when food is present.⁸ This gut-stimulating effect is the main reason co-amoxiclav causes more diarrhea than amoxicillin alone.

For most people, these side effects are mild and resolve once the course finishes. Eating before or alongside your dose, and spreading doses evenly across the day, can reduce the intensity. Probiotics are sometimes recommended, though the evidence for whether they meaningfully prevent antibiotic-associated diarrhea varies.

Liver Injury

One of the more worrying rare side effects is drug-induced liver injury, specifically a pattern where bile flow is disrupted. The typical scenario is that a patient finishes a course of co-amoxiclav, feels fine for a week or two, and then develops jaundice, itching, dark urine, or pale stools. In one published case, a 62-year-old woman developed severe painless jaundice, nausea, and itching less than a week after completing a course, with investigations confirming the antibiotic as the cause.⁹ Another case report documented a 68-year-old whose liver test results worsened progressively after finishing the antibiotic, peaking around day 30.¹⁰

The delay between taking the drug and noticing symptoms is part of what makes this tricky. People often do not connect the jaundice to an antibiotic they finished weeks earlier. The clavulanic acid component is generally considered the culprit, and genetic factors may play a role in who is susceptible.¹¹ Older adults and people who take repeated courses appear to be at higher risk. This side effect is rare enough that it should not scare you away from taking the drug when it is genuinely needed, but it does mean you should tell your doctor if you develop yellowing of the skin or eyes in the weeks after a course.

Allergic Reactions

Because amoxicillin is a penicillin, anyone with a true penicillin allergy should not take co-amoxiclav. Mild reactions like a rash are the most common allergic response, but in rare cases the drug can trigger more severe reactions including hives, swelling of the face or throat, and full anaphylaxis.¹² If you develop difficulty breathing, widespread hives, or facial swelling after taking a dose, seek emergency care immediately. It is worth noting that many people who believe they are allergic to penicillin are actually not; about 90% of people labeled penicillin-allergic turn out to tolerate it fine when formally tested. If you have only a vague memory of being told as a child that you were allergic, an allergy evaluation may be worthwhile since it could open up access to this useful drug class.

The Warfarin Question

You will sometimes see warnings that co-amoxiclav can increase the blood-thinning effect of warfarin, a concern that matters because too much thinning raises the risk of dangerous bleeding. A randomized controlled trial put this to the test and found that co-amoxiclav did not significantly change warfarin’s effect. The average increase in the standard clotting measure was essentially identical between the co-amoxiclav group and the placebo group.¹³ That said, any illness that changes your eating habits or gut function can indirectly affect warfarin levels, and some individual patients do seem to show fluctuations. If you are on warfarin and start co-amoxiclav, your doctor may still want to check your clotting levels partway through the course, but the antibiotic itself does not appear to be the direct cause of interactions that older case reports suggested.

Clostridioides difficile Risk

Any antibiotic that disrupts the normal gut bacteria can set the stage for Clostridioides difficile (formerly called Clostridium difficile) to take hold, causing watery diarrhea that is distinct from the ordinary loose stools many people get during a course of antibiotics. Ampicillin-class drugs and cephalosporins are among the most frequently linked antibiotics for this complication, partly because they are prescribed so often.¹⁴ The key warning sign is diarrhea that starts during or shortly after your course and keeps getting worse, sometimes with fever, cramping, or blood. If you develop those symptoms, contact your doctor rather than assuming it is a normal side effect.

Growing Resistance

Co-amoxiclav is not immune to resistance. Some bacteria have found ways to beat the combination. One mechanism is simply producing vastly larger quantities of beta-lactamase enzymes, enough to overwhelm the clavulanic acid before it can neutralize them all. Research on E. coli from community urinary tract infections found that resistant strains typically produced at least 16-fold more beta-lactamase enzyme than susceptible ones.¹⁵

Another route involves extended-spectrum beta-lactamases (ESBLs), enzymes that can break down a wider range of penicillins and cephalosporins. In a study of community-onset urinary tract infections, about half of ESBL-carrying bacteria were also resistant to co-amoxiclav.¹⁶ Prior exposure to fluoroquinolone antibiotics was identified as one risk factor for harboring these resistant strains. This is one reason doctors increasingly request urine cultures before choosing an antibiotic for urinary infections: knowing what the bacterium is resistant to prevents wasted courses and further selection of resistant bugs.

Storage Matters More Than You Think

Co-amoxiclav tablets should be stored at or below room temperature and kept dry. This sounds like boilerplate advice, but there is a published case of treatment failure directly linked to improper storage. A patient left his co-amoxiclav in a hot car, suspected it had gone bad, threw it away, and never communicated this to his next prescriber. The result was incomplete treatment and a worsening foot infection.¹⁷ Heat breaks down both components, reducing their effectiveness and potentially leaving drug concentrations too low to clear the infection. If you live in a hot climate or are traveling, keep your antibiotics indoors and out of direct sunlight. Liquid formulations are even more sensitive and typically need refrigeration once reconstituted.

What Happens to Your Gut Bacteria

Beyond the immediate digestive side effects, co-amoxiclav has a measurable impact on the bacterial community living in your intestines. A systematic review of the most commonly prescribed antibiotics in primary care found that the amoxicillin-clavulanic acid combination caused mild to moderate shifts in gut bacteria composition, with increases in certain potentially harmful bacteria and decreases in beneficial species like Bifidobacterium and Lactobacillus, along with a general drop in diversity.¹⁸

Recovery timelines varied. Some studies found bacterial levels returned to near-baseline within about five weeks, while one study reported that the gut had not fully normalized even two months after the antibiotic was stopped. This variability probably depends on the individual’s starting gut community, diet, course length, and whether any probiotics or fermented foods were consumed during recovery. For a short course treating a straightforward infection, these shifts are generally reversible. Repeated courses over months are more likely to leave lasting changes.

Pediatric Formulations and Confusion

Children receive co-amoxiclav as a liquid suspension rather than tablets, and the formulations available can be genuinely confusing. Multiple liquid versions exist with different amoxicillin-to-clavulanate ratios, and a national survey of prescribing institutions found that nearly 70% stocked multiple formulations because of varying clinical needs. The 14:1 ratio was the most common choice for ear infections, sinusitis, and respiratory infections in children, but a notable fraction of institutions still used the 4:1 or 2:1 formulations for the same conditions.¹⁹ Over 40% of responding institutions said they deliberately limited the number of liquid formulations available to reduce the risk of dosing errors. If your child is prescribed a liquid co-amoxiclav, double-check the concentration on the bottle label against the dose your doctor wrote down, because a mix-up between formulations can mean your child gets too much clavulanic acid (more diarrhea, more stomach upset) or too little amoxicillin (less effective treatment).